MeSH tree: C05.116.900.853.625
Rheumatic musculoskeletal diseases (RMD) have an important impact on quality of life, and represent an economic burden to society. EULAR—The European Alliance of Associations for Rheumatology—has emphasized the role of patient ...
Jun 13, 2025
0
13
Two studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate, but these did not select for poor prognosis. The aim, therefore, of the SPEED trial (Severe Psoriatic arthritis—Early ...
Jun 11, 2025
0
13
NDORMS researchers have identified a primary source of inflammatory IL-17 driving spondyloarthritis, paving the way for the development of targeted therapies to treat the condition.
Jun 5, 2025
1
20
Delays in diagnosing and treating psoriatic arthritis—a common inflammatory disorder affecting around 200,000 people in the U.K.—are causing irreparable damage to people's health. This damage could be avoided by catching ...
Apr 1, 2025
0
25
Almost a quarter of Australians with back and neck pain have changed their work status due to their conditions, according to the first annual report from the Australian Longitudinal Study on Back and Neck Pain.
Mar 11, 2025
0
16
People with Crohn's disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, with the bacterium Mediterraneibacter gnavus being a potential biomarker, according ...
Mar 5, 2025
0
14
Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study published online Jan. 10 in Medicine.
Jan 29, 2025
0
21
New research led by Keele University and published in the journal BMC Medicine has shown that people with inflammatory arthritis currently using gabapentinoids are more likely to break their bones.
Dec 12, 2024
0
59
There is a strong connection between inflammatory bowel disease (IBD) and spondyloarthritis—a condition that causes pain and stiffness in the joints. The risk is particularly high among patients with Crohn's disease and those ...
Oct 28, 2024
0
23
The U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active psoriatic arthritis (PsA), adults with active nonradiographic axial spondyloarthritis (nr-axSpA) with objective ...
Sep 26, 2024
0
34
